2m 2m 2m 2m 2m 2m 2m
Pfizer (PFE)
NYSE
$24.89-$0.19 (-0.78%)
Price as of Jun 23, 2026 12:35 PM EDT- $142.9BMarket Cap
- 11.66%1-Year Change
- Drug Manufacturers - GeneralIndustry
Pfizer (PFE)
$24.89-$0.19 (-0.78%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 62.6B -1.65% | 63.6B +8.77% | 58.5B -41.70% | 100.3B +23.43% | |
Cost of Revenue | 16.1B -9.99% | 17.9B -28.46% | 25.0B -27.34% | 34.3B +11.43% | |
Gross Profit | 8.2B +7.57% | 7.6B +12.17% | 6.8B +10.59% | 6.1B +7.67% | |
Sales and Marketing Expense | 13.8B -6.35% | 14.7B -0.28% | 14.8B +8.00% | 13.7B +7.67% | |
Research and Development Expense | -10.4B -3.56% | -10.8B +1.34% | -10.7B -6.55% | -11.4B -17.36% | |
Depreciation and Amortization Expense | 6.6B -6.00% | 7.0B +11.49% | 6.3B +74.72% | 3.6B -2.70% | |
Total Operating Expenses | 16.1B -9.99% | 17.9B -28.46% | 25.0B -27.34% | 34.3B +11.43% | |
Operating Profit | 7.5B -6.27% | 8.0B +658.32% | 1.1B -96.95% | 34.7B +42.85% | |
Interest Income | 603.0M +10.64% | 545.0M -66.44% | 1.6B +547.01% | 251.0M +597.22% | |
Interest Expense | -2.7B -13.59% | -3.1B +39.93% | -2.2B +78.43% | -1.2B -4.11% | |
Interest Income and Expense and Net | -2.1B -18.77% | -2.5B +335.21% | -585.0M -40.73% | -987.0M -21.35% | |
Total Nonoperating Income and Expense | -6.7B +53.24% | -4.4B -625.51% | 835.0M +484.79% | -217.0M -104.45% | |
Income before Taxes | 7.5B -6.27% | 8.0B +658.32% | 1.1B -96.95% | 34.7B +42.85% | |
Income Taxes | -266.0M +850.00% | -28.0M -97.49% | -1.1B -133.50% | 3.3B +79.70% | |
Extraordinary Items | 4.9B +49.92% | 3.3B +8.96% | 3.0B +618.29% | 421.0M +389.53% | |
Net Income | 7.8B -3.24% | 8.0B +279.00% | 2.1B -93.25% | 31.4B +42.74% | |
Net Income from Continuing Operations Applicable to Common | 7.5B -6.27% | 8.0B +658.32% | 1.1B -96.95% | 34.7B +42.85% | |
Basic EPS and Net Income | 1.37 -3.52% | 1.42 +273.68% | 0.38 -93.20% | 5.59 +42.60% | |
Diluted EPS and Net Income | 1.36 -3.55% | 1.41 +281.08% | 0.37 -93.24% | 5.47 +42.08% | |
Basic Weighted Average Shares | 5.7B +0.34% | 5.7B +0.37% | 5.6B +0.62% | 5.6B +0.12% | |
Diluted Weighted Average Shares | 5.7B +0.23% | 5.7B -0.16% | 5.7B -0.42% | 5.7B +0.44% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 1.1B +9.49% | 1.0B -63.44% | 2.9B +585.82% | 416.0M -78.60% | |
Short-Term Investments | 9.2B -15.61% | 10.9B +147.30% | 4.4B -76.52% | 18.7B -14.86% | |
Cash and Cash Equivalents and Short-Term Investments | 10.3B -13.41% | 11.9B +64.40% | 7.3B -62.14% | 19.2B -20.03% | |
Total Current Assets | 42.9B -14.81% | 50.4B +16.21% | 43.3B -15.46% | 51.3B -14.13% | |
Accumulated Depreciation | 17.4B +5.48% | 16.5B +2.73% | 16.0B +5.74% | 15.2B +0.66% | |
Property and Plant and Equipment and Net | 19.3B +5.02% | 18.4B -2.89% | 18.9B +16.38% | 16.3B +9.35% | |
Total Long-Term Assets | 9.6B -1.89% | 9.8B -21.28% | 12.5B -5.26% | 13.2B +71.42% | |
Total Assets | 208.2B -2.45% | 213.4B -5.79% | 226.5B +14.86% | 197.2B +8.67% | |
Income Taxes Payable | 5.5B +9.38% | 5.0B +68.35% | 3.0B +14.52% | 2.6B +61.61% | |
Total Short-Term Debt | 3.2B -54.59% | 6.9B -32.89% | 10.3B +251.44% | 2.9B +31.41% | |
Total Current Liabilities | 37.0B -13.98% | 43.0B -10.04% | 47.8B +13.42% | 42.1B -1.25% | |
Total Long-Term Debt | 61.6B +7.38% | 57.4B -6.72% | 61.5B +87.14% | 32.9B -9.15% | |
Total Long-Term Liabilities | 14.7B +4.06% | 14.2B -14.44% | 16.5B +25.49% | 13.2B +35.28% | |
Total Liabilities | 121.4B -2.81% | 124.9B -8.97% | 137.2B +35.47% | 101.3B -2.62% | |
Retained Earnings | 114.6B -1.81% | 116.7B -1.38% | 118.4B -5.81% | 125.7B +21.53% | |
Total Stockholders Equity | 86.5B -1.96% | 88.2B -0.91% | 89.0B -6.95% | 95.7B +23.91% | |
Total Shares Outstanding | 9.6B +0.29% | 9.6B +0.32% | 9.6B +0.45% | 9.5B +0.51% | |
Cash Flow | |||||
Cash from Operating Activities | 11.7B -8.16% | 12.7B +46.48% | 8.7B -70.27% | 29.3B -10.17% | |
Capital Expenditures | 2.6B -9.63% | 2.9B -25.54% | 3.9B +20.74% | 3.2B +19.37% | |
Cash from Investing Activities | -1.4B -150.94% | 2.7B +108.22% | -32.3B +104.51% | -15.8B -30.00% | |
Dividends Paid | 9.8B +2.72% | 9.5B +2.87% | 9.2B +2.94% | 9.0B +2.91% | |
Cash from Financing Activities | -10.3B -39.88% | -17.1B -165.76% | 26.1B +275.72% | -14.8B +51.12% | |
Financials Ratio | |||||
Gross Margin | 74.33% +3.31% | 71.94% +25.47% | 57.34% -12.82% | 65.77% +5.94% | |
Operating Margin | 12.02% -4.70% | 12.61% +597.15% | 1.81% -94.77% | 34.61% +15.74% | |
Return on Assets | 3.69% +0.97% | 3.65% +265.06% | 1.00% -93.96% | 16.57% +26.54% | |
Return on Equity | 8.90% -1.83% | 9.06% +294.96% | 2.29% -93.68% | 36.30% +15.96% | |
Revenue Growth | -1.65% -118.78% | 8.77% +121.04% | -41.70% -278.00% | 23.43% -75.07% | |
Current Ratio | 1.16 -0.97% | 1.17 +29.18% | 0.91 -25.47% | 1.22 -13.04% | |
Cash Ratio | 0.03 +27.16% | 0.02 -59.30% | 0.06 +503.03% | 0.010 -78.29% | |
Debt-to-Equity Ratio | 0.75 +2.70% | 0.73 -9.66% | 0.81 +115.65% | 0.37 -24.78% | |
Debt-to-Assets Ratio | 0.31 +3.22% | 0.30 -4.98% | 0.32 +74.68% | 0.18 -14.21% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow